Spitalul Judetean de Urgenta "Sfantul Ioan cel Nou" Suceava

Suceava 720237

1 studies enrolling now · 4 studies all time

What they study most

Complete Response, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Partial Response, Primary Peritoneal, Refractory Metastatic Gastric Cancer

Studies at this site

• A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes — Recruiting now
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed